Premium
Rutin‐Associated Hepatoprotection: A Review of Mechanisms and Therapeutic Prospects
Author(s) -
Feng Yanting,
Peng Lanchun,
Liu Xiaohui,
Zheng Qingzhu,
Qian Min,
Deng Meiling,
Peng Jiangli,
Li Yamei,
Lin Limei,
Peng Qiuxian
Publication year - 2025
Publication title -
basic and clinical pharmacology and toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.805
H-Index - 90
eISSN - 1742-7843
pISSN - 1742-7835
DOI - 10.1111/bcpt.70042
ABSTRACT Background Liver disorders pose a considerable global health challenge, accompanied by rising mortality rates. Current therapeutic strategies, though effective, often face limitations due to adverse effects and therapeutic resistance, prompting the exploration of alternative treatments, particularly safer natural compounds. Rutin, a widely available bioflavonoid, has emerged as a promising candidate owing to its varied pharmacological properties. Methods We conducted a comprehensive search on PubMed and Web of Science using the following keywords: ‘rutin’, ‘liver diseases’, ‘hepatoprotection’, ‘clinical observations’, ‘mechanisms, pharmacology’ and various combinations of these terms. Results This review systematically examines rutin's therapeutic potential in hepatic disorders, focusing on its molecular mechanisms, particularly its effects on inflammatory pathways, oxidative stress and hepatocellular protection. Conclusion We analyse existing evidence supporting rutin's hepatoprotective efficacy, identify its cellular and molecular targets and evaluate its potential applications in various liver diseases. Our systematic analysis provides theoretical support for developing rutin‐based therapies in hepatic disease management and identifies future research directions and clinical applications.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom